Careseng NutroPro H
Natural health product licensed in Canada
- Licence holder
- Pegasus Pharmaceuticals Group Inc.
- NPN or DIN-HM
- 80031868
- Status
- Active licence
- Licence date
- 1 May 2012
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| trans-Resvératrol Source : Fallopia japonica - Racine | 10 mg | Not calculated |
| trans-Resvératrol Source : Resvératrol | 10 mg | Not calculated |
| Solanum lycopersicum Source : Chair (fruit) Extraction ratio : 20:1 Dry plant equivalent : 560 mg Potency : 7 % Lycopene | 28 mg | Not calculated |
Non-medicinal ingredients
D-glucose monohydraté, Stéarate de magnésium, Croscarmellose de sodium, Acide stéarique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Source of antioxidants for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you have a liver disorder or develop liver-related symptoms (e.g. abdominal pain, jaundice, dark urine). Consult a health care practitioner prior to use if you are taking blood thinners. Consult a health care practitioner prior to use if you have kidney disease, gallstones, stomach ulcers or excess stomach acid, hormone-sensitive cancer. Consult a health care practitioner prior to use if you are taking hormone replacement therapy (HRT) , including thyroid hormone replacement therapy. Ensure you are up-to-date on mammograms and gynaecological evaluations prior to use. Consult a health care practitioner prior to use if you have a history of hormonal or gynaecological disease, including ovarian cancer, endometriosis, and/or uterine fibroids. Discontinue use and consult a health care practitioner if you experience breast pain, discomfort and/or tenderness, or if you experience a recurrence of menstruation and/or uterine spotting.
Source
Official Health Canada record, licence 80031868
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.